Robert G Finizio Insider Trading $TXMD TherapeuticsMD, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert G Finizio.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert G Finizio. Robert G Finizio is CEO in TherapeuticsMD, Inc. ($COFF) and Chairman/CEO in TherapeuticsMD, Inc. ($COFF).
Robert G Finizio in TherapeuticsMD, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert G Finizio: Chairman/CEO
Holdings: 18,059,334 shares
Latest Transaction: May 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert G Finizio in TherapeuticsMD, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.00 | 158,334 | 0 | 316,666 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 1.04 | 67,697 | 70,405 | 17,991,637 | 18.1 M to 18 M (-0.37 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.00 | 158,334 | 0 | 18,059,334 | 17.9 M to 18.1 M (+0.88 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | X | 0.24 | 179,000 | 43,748 | 0 | |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 300,000 | 0 | 17,901,000 | 18.2 M to 17.9 M (-1.65 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 350,000 | 0 | 18,201,000 | 18.6 M to 18.2 M (-1.89 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Payment of Exercise | F | 1.46 | 29,964 | 43,747 | 18,551,000 | 18.6 M to 18.6 M (-0.16 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | X | 0.24 | 179,000 | 43,748 | 18,580,964 | 18.4 M to 18.6 M (+0.97 %) |
| Nov 27 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 0.00 | 1 | 0 | 1 | |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.47 | 25,000 | 36,750 | 18,401,964 | 18.4 M to 18.4 M (+0.14 %) |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.41 | 21,000 | 29,610 | 18,376,964 | 18.4 M to 18.4 M (+0.11 %) |
| Jun 08 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.15 | 20,000 | 23,000 | 18,355,964 | 18.3 M to 18.4 M (+0.11 %) |
| Jun 08 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.16 | 10,000 | 11,600 | 18,335,964 | 18.3 M to 18.3 M (+0.05 %) |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 0.00 | 475,000 | 0 | 475,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 0.00 | 475,000 | 0 | 475,000 | |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 2.75 | 72,000 | 198,000 | 18,325,964 | 18.3 M to 18.3 M (+0.39 %) |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 2.73 | 1 | 3 | 1 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 2.73 | 1 | 3 | 1 | |
| Aug 20 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 2.74 | 35,000 | 95,900 | 18,253,964 | 18.2 M to 18.3 M (+0.19 %) |
| Aug 12 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 2.96 | 52,405 | 155,119 | 18,218,964 | 18.2 M to 18.2 M (+0.29 %) |
| Aug 12 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 200,000 | 0 | 18,166,559 | 18.4 M to 18.2 M (-1.09 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,910 | 9,458 | 0 | |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 92,910 | |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 3.63 | 92,910 | 336,892 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,910 | 9,458 | 18,459,469 | 18.4 M to 18.5 M (+0.51 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 3.70 | 92,000 | 340,216 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,458,559 | 18.4 M to 18.5 M (+0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 184,910 | |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 276,910 | |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.60 | 92,000 | 423,568 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,458,559 | 18.4 M to 18.5 M (+0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.57 | 92,000 | 420,624 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,458,559 | 18.4 M to 18.5 M (+0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 27,000 | 0 | 18,366,559 | 18.4 M to 18.4 M (-0.15 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 368,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 368,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 460,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 460,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.81 | 92,000 | 442,060 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.81 | 92,000 | 442,060 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.86 | 92,000 | 447,028 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.86 | 92,000 | 447,028 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 736,910 | |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 828,910 | |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.12 | 92,000 | 470,764 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.45 | 92,000 | 501,308 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 920,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 920,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,012,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,012,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.45 | 92,000 | 501,216 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.45 | 92,000 | 501,216 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.65 | 92,000 | 519,616 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.65 | 92,000 | 519,616 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,104,910 | |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,196,910 | |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.67 | 92,000 | 613,640 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.58 | 92,000 | 605,360 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,288,910 | |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,380,910 | |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.22 | 92,000 | 572,240 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.25 | 92,000 | 575,000 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 5.16 | 440,000 | 2,270,400 | 440,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 5.16 | 440,000 | 2,270,400 | 440,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 6.83 | 445,000 | 3,039,350 | 445,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 8.92 | 950,000 | 8,474,000 | 950,000 | |
| Apr 17 2012 | COFF | TherapeuticsMD, In ... | Finizio Robert G | Chairman/CEO | Option Exercise | A | 2.55 | 50,000 | 127,500 | 2,027,481 | |
| Mar 16 2012 | COFF | TherapeuticsMD, In ... | Finizio Robert G | Chairman/CEO | Option Exercise | A | 2.20 | 300,000 | 660,000 | 1,977,481 |
Page: 1